RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 537 JPY 0.37% Market Closed
Updated: May 31, 2024
RaQualia Pharma Inc
/
Income Statement
/
Interest Income Expense

RaQualia Pharma Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RaQualia Pharma Inc
Interest Income Expense Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
RaQualia Pharma Inc
TSE:4579
Interest Income Expense
¥54.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-24%
Takeda Pharmaceutical Co Ltd
TSE:4502
Interest Income Expense
-¥161.3B
CAGR 3-Years
12%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Interest Income Expense
¥25.6B
CAGR 3-Years
136%
CAGR 5-Years
47%
CAGR 10-Years
96%
Otsuka Holdings Co Ltd
TSE:4578
Interest Income Expense
¥30.7B
CAGR 3-Years
25%
CAGR 5-Years
8%
CAGR 10-Years
9%
Chugai Pharmaceutical Co Ltd
TSE:4519
Interest Income Expense
¥3.3B
CAGR 3-Years
N/A
CAGR 5-Years
40%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Interest Income Expense
-¥3.7B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-10%

See Also

What is RaQualia Pharma Inc's Interest Income Expense?
Interest Income Expense
54.4m JPY

Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Interest Income Expense amounts to 54.4m JPY.

What is RaQualia Pharma Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-24%

Over the last year, the Interest Income Expense growth was -17%.

ALPHA SPREAD
Join more than 142,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.